AcelRx Pharma (ACRX) Tops Q2 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. JBLU
2. META
3. PECO
4. SSD
5. AVGO
6. CDNS
7. AGYS
8. HWKN
9. INTC
10. RMBS

Go back to AcelRx Pharma (ACRX) Tops Q2 EPS by 6c

AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results

August 10, 2020 4:01 PM EDT

REDWOOD CITY, Calif., Aug. 10, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its second quarter 2020 financial results.

"Despite the challenges with COVID in the second quarter, we made meaningful progress towards generating long-term shareholder value and expanding the DSUVIA launch through advancements with the Department of Defense and our exclusive agreement with Zimmer Biomet for dental surgeries," said Vince Angotti, Chief Executive Officer of AcelRx. "We expect these two... More